Tasly Holding Group
2000
FOUNDED
PUBLIC
STATUS
5K-10K
EMPLOYEES
600535
STOCK SYMBOL
26
INVESTMENTS
$2.20
SHARE PRICE
(As of Thursday Closing)
Description
Tasly Pharmaceutical Group Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. Its herbal medicines include Tasly Cerebral Care Granules and Tasly ICP. Its chemical medicines comprise of Ketotifen Fumarate Tablets, Thiamphenicol Capsules, Glucurolactone Tablets and Sulpiride Tablets. Some of the other products offered by the company include PharmceuticalSubstances & API, HerbalExtract, and Concentrated Herbal Granules.
Website
Formerly Known As
Tianjin Tasly Pharmaceutical
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
SHG
Primary Office
- Tasly Modern TCM Building
- No. 2, Pujihe East Road Beichen District
- Tianijn, 300410
- China
+86 00000000000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Tasly Holding Group’s full profile, request a free trial.
Tasly Holding Group Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $2.06 - $3.76 | $3.33B | $2.22 | $0.15 | 14.6M | 1.51B |
Tasly Holding Group Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 4,526,975 | 5,075,497 | 6,899,175 | 6,718,148 |
| Revenue | 2,774,530 | 2,719,392 | 2,381,514 | 2,093,658 |
| EBITDA | 401,376 | 419,769 | 354,665 | 305,224 |
| Net Income | 222,582 | 233,576 | 203,692 | 176,618 |
| Total Assets | 3,617,098 | 3,659,230 | 3,298,032 | 2,466,412 |
| Total Debt | 1,079,583 | 1,302,585 | 1,200,910 | 401,475 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Tasly Holding Group Investments & Acquisitions (26)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 0000000 00 | 16-Oct-2019 | 00000 00000 00 | 000.00 | Pharmaceuticals | |
| 0000000 000000 | 24-Sep-2019 | 00000 00000 00 | 00.000 | Biotechnology | |
| 0000 0000000 | 30-Aug-2019 | 00000 00000 00 | 000.00 | Therapeutic Devices | |
| 00000000000000000 | 26-Jul-2019 | 00000 00000 00 | 00000 | Biotechnology | |
| Zhangshang Tangyi | 07-Jan-2019 | Later Stage VC | 00000 | Application Software |
Tasly Holding Group Exits (4)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000000000 000000 | 23-Mar-2017 | 00 000000000000000 | 00000 | Completed |
|
| 00000000 | 03-Jan-2017 | 00000 00000 00 | 00000 | Completed |
|
| 00000000 | 02-Sep-2015 | 00000 00000 00 | 0000 | Completed |
|
| Tianzhenshi Biotechnology Company | Early Stage VC | Completed |
|
Tasly Holding Group Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000 0000000000 | Pharmaceuticals | Tianjin, China | 0000 |
Tasly Holding Group Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Tasly Holding Group‘s full profile, request access.
Request full access to PitchBookTasly Holding Group Executive Team (1)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Kaijing Yan | Founder, Chairman & Chief Executive Officer |
Tasly Holding Group Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000000 000 | Tasly Holding Group | Founder, Chairman & Chief Executive Officer | 000 0000 | |
| 00000 000 | Tasly Holding Group | Board Member | 000 0000 |